138 related articles for article (PubMed ID: 5158422)
1. [Treatment of scleroderma].
Holzmann H; Korting GW; Morsches B
Actas Dermosifiliogr; 1971; 62(1):1-12. PubMed ID: 5158422
[No Abstract] [Full Text] [Related]
2. [Treatment of scleroderma].
Korting GW; Holzmann H
Clin Ter; 1967 Feb; 40(4):307-12. PubMed ID: 6077852
[No Abstract] [Full Text] [Related]
3. [Treatment of "collagen and autoimmune" diseases (author's transl)].
Kerl H; Klein G; Sandhofer M
Wien Klin Wochenschr; 1973 Nov; 85(47):769-74. PubMed ID: 4757177
[No Abstract] [Full Text] [Related]
4. [Treatment of scleroderma].
Holzmann H; Korting GW
Dtsch Med Wochenschr; 1968 Sep; 93(36):1721-2. PubMed ID: 5668267
[No Abstract] [Full Text] [Related]
5. Coexistence of recurrent generalized morphea and systemic sclerosis.
Hayashi M; Ichiki Y; Kitajima Y
Acta Derm Venereol; 2009; 89(3):329-30. PubMed ID: 19479146
[No Abstract] [Full Text] [Related]
6. [On some essential differences of scleroderma, dermatomyositis and acute lupus erythematosus and the variegated therapy based on them].
Korting GW
Dtsch Med Wochenschr; 1967 Feb; 92(7):281-8. PubMed ID: 6019059
[No Abstract] [Full Text] [Related]
7. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
8. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
9. Photochemotherapy for systemic and localized scleroderma.
De Rie MA; Bos JD
J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
[No Abstract] [Full Text] [Related]
10. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
11. [Use of Tebessal in scleroderma].
Mattos O; de Oliveira Neto MP
Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
[No Abstract] [Full Text] [Related]
12. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
13. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
14. [Corticostesteroids in the treatment of scleroderma].
Szczepański A
Przegl Dermatol; 1971; 58(6):749-53. PubMed ID: 5139315
[No Abstract] [Full Text] [Related]
15. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
16. [The course of scleroderma following treatment with carnitin].
Nitzschner H
Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
[No Abstract] [Full Text] [Related]
17. [Trafuril reaction in scleroderma].
Urban J
Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
[No Abstract] [Full Text] [Related]
18. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
19. Peristomal morphoea in a patient with systemic sclerosis.
Jiang KW; Zagarella SS; Chan L; Harris A
Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
[No Abstract] [Full Text] [Related]
20. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
